Global /South Korea /Healthcare /Drug Manufacturers - General /123330
chevron_leftBack
Genic Co., Ltd. logo

Genic Co., Ltd.

123330
KRX: 123330 Delayed
29,450KRW 4.1%
19.40 USD
As of 16 June 2026, Genic Co., Ltd. has a market cap of $151.8M USD, ranking #22816 globally and #986 in South Korea. It ranks #2049 in the Healthcare sector, and #738 in the Drug Manufacturers - General industry.
Global Rank
22816
Country Rank
986
Sector Rank
2049
Industry Rank
738
Key Stats
Market Cap
$151.8MUSD
230.44B KRW
Enterprise Value
$144.86MUSD
219.9B KRW
Revenue (TTM)
$51.51MUSD
78.2B KRW
EBITDA (TTM)
$11.16MUSD
16.94B KRW
Net Income (TTM)
$12.44MUSD
18.89B KRW
EBITDA Margin
22%
Profit Margin
24%
PE Ratio
12.2
PS Ratio
2.9
PB Ratio
5.6
EV/EBITDA
13.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Heo Nam open_in_new
Employees
324
Founded
2001
Website
genic21.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
4.1% -6% -13% 48% 43% 22%

News

Loading...

Markets

Exchange Ticker Price
Korea Exchange
MIC: XKRX
PRIMARY
123330
(주)제닉
ISIN: KR7123330003
Shares Out.:
7.825M1 Shares Float: 4.638M2
TV:
SA:
YF:
GF:
BA:
MS:
29,450 KRW
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Genic Co., Ltd.

Genic Co., Ltd. researches, develops, manufactures, and sells cosmetics and pharmaceuticals in South Korea and internationally. The company provides hydrogel masks, sheet masks, cream wrapping masks, mud masks, and bio cellulose masks; nose patch, eye patch, body patch, eye gel, lifting patch, and outdoor patches; cleanser, toner, lotion, serum, cream, sunscreen, and cleansing/soothing/oil pad; and shampoo and tonic. It offers its products under the CELEDERMA, CELEDERMA daily, and Excuse my Frank brands. Genic Co., Ltd. was founded in 2001 and is headquartered in Seongnam-si, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)
Name
Market Cap diff.
PE
$9.16B
13.91T KRW
6K%
-
$6.79B
10.3T KRW
4K%
1958.1
$5.25B
7.97T KRW
3K%
29.9
298380
$4.97B
7.55T KRW
3K%
-
000100
$4.56B
6.92T KRW
3K%
35.9
$4.45B
6.76T KRW
3K%
-
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
502K%
38.1
JNJ
$547.28B
360K%
26.4
ABBV
$360.63B
237K%
97.4
$320.51B
256.25B CHF
211K%
19.9
AZN
$288.14B
215.59B GBP
190K%
27.6
MRK
$274.03B
180K%
15.1
chevron_leftBack